Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for Q9992. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
30
Median % of Medicare
--
Rate range
$1,674.80 - $2,312.13
Q9992 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Alabama | $2,016.42 | -- | -- | 2026 |
| Arkansas | $1,674.80 | -- | -- | 2026 |
| Arizona | $1,835.22 | -- | -- | 2026 |
| California | $2,001.02 | -- | -- | 2026 |
| Connecticut | $1,998.53 | -- | -- | 2026 |
| District of Columbia | $1,998.53 | -- | Not required | 2026 |
| Iowa | $1,945.08 | -- | -- | 2025 |
| Illinois | $1,942.65 | -- | -- | 2026 |
| Indiana | $2,312.13 | -- | Required | 2026 |
| Kansas | $2,068.16 | -- | -- | 2026 |
| Kentucky | $1,998.53 | -- | -- | 2026 |
| Maryland | $1,998.53 | -- | -- | 2026 |
| Maine | $2,068.16 | -- | -- | 2026 |
| Michigan | $2,068.16 | -- | -- | 2026 |
| Minnesota | $2,068.15 | -- | Required | 2026 |
| Mississippi | $1,996.56 | -- | -- | 2026 |
| Montana | $1,998.53* | -- | Required | 2026 |
| Nebraska | $2,068.15 | -- | -- | 2026 |
| New Hampshire | $2,202.03 | -- | Not required | 2026 |
| New Jersey | $1,901.30 | -- | Not required | 2026 |
| New Mexico | $1,931.81 | -- | -- | 2025 |
| Oklahoma | $1,996.56 | -- | -- | 2026 |
| South Carolina | $2,068.16 | -- | -- | 2026 |
| Texas | $1,976.55* | -- | -- | 2026 |
| Utah | $2,068.16* | -- | Required | 2026 |
| Virginia | $2,068.15 | -- | -- | 2026 |
| Vermont | $1,915.60 | -- | -- | 2026 |
| Washington | $2,068.16 | -- | -- | 2026 |
| Wisconsin | $2,068.16 | -- | -- | 2026 |
| Wyoming | $2,068.16 | -- | -- | 2026 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related state-specific services codes
- C1716 - Brachytherapy source, non-stranded, gold-198, per source
- C1717 - Brachytherapy source, non-stranded, high dose rate iridium-192, per source
- C1719 - Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
- C2616 - Brachytherapy source, non-stranded, yttrium-90, per source
- C2634 - Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source
- C2635 - Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source
- C2636 - Brachytherapy linear source, non-stranded, palladium-103, per 1 mm
- C2638 - Brachytherapy source, stranded, iodine-125, per source
All 22 codes from Q9950 to Q9999 or every state-specific services code by number.
Frequently asked questions
How much does Medicaid pay for Q9992?
30 state Medicaid programs publish a fee-for-service rate for Q9992 (injection, buprenorphine extended-release (sublocade), greater than 100 mg), ranging from $1,674.80 in Arkansas to $2,312.13 in Indiana. The full table on this page lists every publishing state's current rate.
Which state pays the most for Q9992?
Indiana publishes the highest Medicaid rate for Q9992 at $2,312.13. Arkansas publishes the lowest at $1,674.80.
Does Q9992 require prior authorization under Medicaid?
4 of the 30 publishing states flag Q9992 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".